Navigation Links
Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference

lizers may offer the easiest method because they require no special technique or coordination, as the medication is converted into a fine mist that the patient inhales through a mouthpiece or face-mask while breathing naturally. Because nebulization is an easy, effective, and thorough method of delivering medicine directly into the lungs, many COPD patients prefer it, particularly as they become increasingly frail due to their disease progression.

Perforomist™ Inhalation Solution changes the paradigm regarding nebulization. Now, nebulization may become a more valuable and widely used treatment option for the millions of COPD patients at earlier treatment stages who would benefit from twice-daily maintenance dosing of a nebulized LABA such as Perforomist™ Inhalation Solution. For example, the clinical benefit of this new COPD treatment may be a valuable clinical option for patients who are not adequately controlled with short-acting bronchodilators.

For those attending ATS, the two presentations are available as follows:

• “Nebulized Formoterol is an Effective Bronchodilator and Improves the Quality of Life for COPD Patients,” Poster Board #A10, Publ. pg. A128.

• “Safety Profile of Formoterol Fumarate Delivered by Nebulization to COPD Patients,” Poster Board #A11, Publ. pg. A128

Poster Viewing: 10:45 AM - 12:15 PM
Room: Area A (Hall D, Lower Level), Moscone Center
Session Info: Thematic Poster Session, [A47] COPD Treatment I: Bronchodilators, Inhaled Corticosteroids and PDE4 Inhibitors.

Please note that the principal investigators will be available to discuss the research results.

Indication
Perforomist™ Inhalation Solution is indicated for the long-term, twice-daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis an
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:7/30/2015)... N.J. , July 30, 2015  Unichem Pharmaceuticals ... recalling one lot of Hydrochlorothiazide tablets 25 mg 1000-count ... initiated as a precautionary measure due to the identification ... the product. The risk associated with ... tablet is the increased probability of experiencing Clopidogrel,s side ...
(Date:7/30/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced the ... of Warburg Pincus LLC, to the Amgen Board of Directors. ... Hassan and the deep, global experience he brings in ... A. Bradway , chairman and chief executive officer of Amgen. "Fred,s ... Amgen well." Mr. Hassan has been Partner and ...
(Date:7/30/2015)... -- Growth of the U.S. nonprescription market is primarily driven ... to the OTC market. Due to an increasingly favorable ... activity over the next five years with several all ... entering the market into existing categories. If ... those with low to moderate likelihood), the market is ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... announces that a new market research report ... IP Overview – "Monoclonal Antibodies ... http://www.reportlinker.com/p0296354/IP-Overview-–-"Monoclonal-Antibodies-against-digestive-system-cancers"-Patent-Landscape-2010.html ... digestive system cancers, monoclonal antibody-based therapies have ...
... MORRISVILLE, N.C., Sept. 21 During the recent ... the European Association of Cardiac Thoracic Surgeons in ... Surgery from University Medical Center in Ljubljana, Slovenia ... professionals to think differently about existing atrial fibrillation ...
Cached Medicine Technology:Reportlinker Adds IP Overview - "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010 2Reportlinker Adds IP Overview - "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010 3Interdisciplinary Convergent Approach May Represent Future for Treatment of Atrial Fibrillation 2Interdisciplinary Convergent Approach May Represent Future for Treatment of Atrial Fibrillation 3
(Date:7/31/2015)... ... July 31, 2015 , ... Transfinder, a software company based in Schenectady, N.Y., ... 16 percent year-over-year for the first six months ended June 30, 2015 compared with ... to beat last year’s record-revenue mark of $10.4 million. , “We know what our ...
(Date:7/31/2015)... ... July 31, 2015 , ... Mullin/Ashley Associates , ... the 2015 Aster Awards national competition for a marketing communications campaign created for ... surrounding communities in Coastal Maryland and Southern Delaware. , A Bronze Award was ...
(Date:7/31/2015)... ... July 31, 2015 , ... Like nearly every other form of surgery, ... upgraded, made more effective and less intrusive and painful. Leading these advances in ... Dr. Loria currently stands as the only doctor in the United States who ...
(Date:7/31/2015)... York, NY and Rockport, ME (PRWEB) , ... July 31, 2015 , ... The alarm ... photo op. , Glancing out of the window, he recalled that his equipment was ... 215 Chrystie Street tower, he jumped out of bed. , The photo speaks for ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reputable source of authentic ... National Soccer Team will face the Australia Women's National Team in two separate friendly ... Field in Detroit and the second match will occur in Birmingham, Alabama at Legion ...
Breaking Medicine News(10 mins):Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Mullin/Ashley Associates Wins in the 2015 Aster Awards National Competition for Excellence in Medical Marketing 2Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2
... developed and began implementing a Strategic Plan,while facilities ... to,improve patient safety while implementation of Act 52 ... HARRISBURG, Pa., April 30 The Pennsylvania,Patient ... outlining,its Strategic Plan that aligns its activities more ...
... Inc.,(Nasdaq: IFLG ), a leading technology provider ... industries, will host a,conference call with the financial ... Company,s First Quarter 2008 financial results and provide ... ), Interested parties may participate in ...
... announces,the launch of a new microsite featuring its ... to complement Baxa direct sales efforts,and features an ... the site,s interactive tools to explore MedBoard features,and ... asked,questions and key product attributes., "The microsite ...
... vaccines for new flu strains, other health threats ... Researchers have devised a rapid and efficient method ... called monoclonal antibodies, which mark and neutralize foreign ... accelerate the traditionally challenging task of generating human ...
... release is also available in French . ... older teens dont necessarily eat a healthier diet than ... no link between body mass index (BMI) values and ... study of 900 Vancouver-area teenagers in Grades 10 through ...
... April 30 T.J. Harkins, President of,TriMix Laboratories ... dysfunction product, TriMix-gel(TM), will be presented at a,moderated ... May 20, 2008 in Orlando, FL. The study ... FAILED PHOSPHODIESTERASE INHIBITORS., The abstract evaluates TriMix-gel ...
Cached Medicine News:Health News:Patient Safety Authority Issues Annual Report for 2007 2Health News:Patient Safety Authority Issues Annual Report for 2007 3Health News:Patient Safety Authority Issues Annual Report for 2007 4Health News:Patient Safety Authority Issues Annual Report for 2007 5Health News:Patient Safety Authority Issues Annual Report for 2007 6Health News:Patient Safety Authority Issues Annual Report for 2007 7Health News:Patient Safety Authority Issues Annual Report for 2007 8Health News:Patient Safety Authority Issues Annual Report for 2007 9Health News:Patient Safety Authority Issues Annual Report for 2007 10Health News:Patient Safety Authority Issues Annual Report for 2007 11Health News:Patient Safety Authority Issues Annual Report for 2007 12Health News:Patient Safety Authority Issues Annual Report for 2007 13Health News:Patient Safety Authority Issues Annual Report for 2007 14Health News:Patient Safety Authority Issues Annual Report for 2007 15Health News:Patient Safety Authority Issues Annual Report for 2007 16Health News:Patient Safety Authority Issues Annual Report for 2007 17Health News:Patient Safety Authority Issues Annual Report for 2007 18Health News:InfoLogix to Report First Quarter Results on April 30, 2008 - Conference Call Information 2Health News:Baxa Launches Microsite Featuring the MedBoard(TM) Medication Tracking System 2Health News:Researchers Develop Quick Way to Create Human Antibodies 2Health News:Researchers Develop Quick Way to Create Human Antibodies 3Health News:Physical activity, healthy eating and BMI not linked in older teens: study 2Health News:TriMix-gel vs Viagra, Levitra, Cialis Data to Be Presented at AUA 2
... The Research Family includes fixed-volume, adjustable-volume, ... the electronic Eppendorf Research pro Pipette. ... these compact, high-performance pipettes have earned ... suited for use with original Eppendorf ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... is ideal for repeated pipetting ... volume FInnpipettes offer the same ... Finnpipette Digital pipettes: New, ... Soft-touch tip ejection, Safety label, ...
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Medicine Products: